Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
PaperCitations, authors & open-access status
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 447 citations, 2020 year and bronze oa status.
447
Citations
2020
Year
bronze
OA Status